Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Research Article

Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy

Online download statistics by month:

Online download statistics by month: December 2019 to April 2023

	Abstract	Full	Pdf
Dec 2019	3	3	0
Jan 2020	6	6	1
Feb 2020	5	5	1
Mar 2020	14	14	1
Apr 2020	18	18	2
May 2020	18	18	2
Jun 2020	9	9	2
Jul 2020	16	16	2
Aug 2020	10	10	0
Sep 2020	28	28	2
Oct 2020	23	24	4
Nov 2020	18	17	2
Dec 2020	11	10	1
Jan 2021	10	10	0
Feb 2021	6	6	2
Mar 2021	15	15	2
Apr 2021	8	8	4
May 2021	8	8	6
Jun 2021	14	14	2
Jul 2021	14	14	1
Aug 2021	11	11	2
Sep 2021	27	27	4
Oct 2021	13	13	3
Nov 2021	16	16	5
Dec 2021	13	13	1
Jan 2022	17	19	6
Feb 2022	11	11	2
Mar 2022	22	24	2
Apr 2022	26	28	5
May 2022	29	29	3
Jun 2022	24	24	3
Jul 2022	26	27	4
Aug 2022	28	28	2
Sep 2022	20	20	0
Oct 2022	20	20	1
Nov 2022	13	15	12
Dec 2022	10	10	1
Jan 2023	18	18	1
Feb 2023	27	27	1
Mar 2023	10	11	4
Apr 2023	7	8	5
Total	642	652	104